2025-11-06 - Analysis Report
Okay, here's an analysis of Northrop Grumman (NOC) based on the provided data, formatted as requested:

## Northrop Grumman (NOC) Analysis

Northrop Grumman Corp is an aerospace and defense company providing advanced technology systems and products.

### 1. Performance vs. S&P 500 (VOO)

*   **NOC Cumulative Return:** 46.33%
*   **VOO Cumulative Return:** 99.52%
*   **Absolute Divergence:** -50.4%
*   **Divergence Range:** Max: 56.8, Min: -54.9
*   **Relative Divergence:** 4.0

**Analysis:** NOC has significantly underperformed the S&P 500 over the period examined.  The relative divergence of 4.0 indicates that NOC's underperformance is near the lowest end of its historical divergence range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha | Beta | Cap(B) |
|------------|--------|-------|-------|------|--------|
| 2015-2017  | 46.0%  | 65.6% | 17.0% | 0.0  | 43.8   |
| 2016-2018  | -2.0%  | 74.3% | -17.0% | 0.0  | 35.0   |
| 2017-2019  | 17.0%  | 79.2% | -5.0% | 0.9  | 49.1   |
| 2018-2020  | -28.0% | 79.9% | -52.0% | 0.8  | 43.5   |
| 2019-2021  | 43.0%  | 79.9% | -4.0%  | 0.8  | 55.2   |
| 2020-2022  | 18.0%  | 79.9% | 19.0%  | 0.3  | 77.9   |
| 2021-2023  | 24.0%  | 82.7% | 23.0%  | 0.2  | 66.8   |
| 2022-2024  | -15.0% | 82.7% | -36.0% | 0.2  | 67.0   |
| 2023-2025  | -4.0%  | 82.1% | -68.0% | 0.1  | 81.4   |

**Analysis:**

*   **CAGR & MDD:** The table shows fluctuating Compound Annual Growth Rates (CAGR) and consistently high Maximum Drawdowns (MDD), indicating volatile performance.
*   **Alpha:** Alpha is inconsistent, swinging from positive to negative values, suggesting NOC's performance is not consistently outperforming its benchmark.  The negative Alpha in recent periods (2022-2025) is particularly concerning.
*   **Beta:** Beta values are generally low, suggesting NOC is less sensitive to market movements than the S&P 500.
*   **Cap(B):**  Market Cap has generally increased over the periods.

### 2. Recent Stock Price Movement

*   **Current Price:** 570.425
*   **Last Market Data:** {'price': 570.425, 'previousClose': 577.14, 'change': -1.16}
*   **5-Day Moving Average:** 578.575
*   **20-Day Moving Average:** 601.4212
*   **60-Day Moving Average:** 592.3454

**Analysis:** The current price is below all three moving averages (5-day, 20-day, and 60-day), indicating a recent downward trend. The price decreased by -1.16 compared to the previous close, suggesting a slightly negative market reaction.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 26.44 (Oversold)
*   **PPO:** -0.76
*   **Hybrid Signal:** cash_69%_Sell 0.9% of holdings (1 shares - Caution - MRI:0.60)
*   **Recent (20-day) Relative Divergence Change:** -6.2 (Short-term decline)
*   **Expected Return:** -109.3% (Long-term, relative to S&P 500)

**Analysis:**

*   The high MRI suggests that based on broader market conditions, investment is recommended, however, the Hybrid Signal gives a sell advice due to MRI decreasing to 0.6
*   The RSI is in oversold territory, which *could* suggest a potential for a price rebound, but it also could indicate continued downward momentum.
*   The negative PPO supports the downward trend indicated by the moving averages.
*   The significant negative expected return (-109.3%) indicates a pessimistic outlook for NOC's long-term performance relative to the S&P 500.
*   The change from previous close {-1.16} suggests recent negative impact

### 4. Recent News & Significant Events

*   **[2025-11-05]** Navigating Volatility: How Defense ETFs' Dip Offers Long-Run Opportunity (Zacks)
*   **[2025-11-05]** Northrop Grumman (NOC): Fresh Analyst Optimism Sparks Debate on Stock’s Fair Value and Growth Outlook (Simply Wall St.)
*   **[2025-11-05]** Northrop Grumman to Participate in the Baird 2025 Global Industrial Conference (GlobeNewswire)
*   **[2025-11-04]** UBS Reiterates Bullish View on Grumman Corp. (NOC), Cites Robust Multi-Year Growth Outlook (Insider Monkey)
*   **[2025-11-04]** Leidos Holdings Beats Q3 Earnings Estimates, Raises '25 View (Zacks)
*   **[2025-11-04]** Analyst Report: Northrop Grumman Corp. (Argus Research)

**Analysis:**  The news is mixed. While some articles express optimism about NOC's growth outlook and fair value (Simply Wall St., UBS, Argus Research), others focus on volatility in the defense sector (Zacks).  NOC's participation in the Baird conference suggests efforts to engage with investors.  The positive earnings report from Leidos, a competitor, could be a positive signal for the sector in general, but it doesn't directly impact NOC.

#### 4-2) Analyst Opinions:

*   **Consensus:** Buy (Mean = 2.10)
*   **Target Price:** 664.83 (Average) / 770.00 (High) / 533.00 (Low)

**Analysis:**  Analysts, on average, have a "Buy" rating on NOC and a target price significantly higher than the current price, suggesting potential upside. However, the wide range between the high and low target prices indicates uncertainty. The details of Recent Rating Changes are missing.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출       |
|--------------|------|------------|
| 2025-10-21   | 7.69 | 10.42 B$   |
| 2025-07-22   | 8.17 | 10.35 B$   |
| 2025-04-22   | 3.33 | 9.47 B$    |
| 2024-10-24   | 7.02 | 10.00 B$   |
| 2025-10-21   | 7.02 | 10.00 B$   |

**Analysis:** Earnings per share (EPS) has fluctuated, with a noticeable dip in Q2 2025. Revenue has been relatively stable.  The duplicated row of 2025-10-21 needs to be reviewed for correction.

### 6. Financial Information

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $10.35B    | 21.35%        |
| 2025-03-31   | $9.47B     | 16.69%        |
| 2024-12-31   | $10.69B    | 18.08%        |
| 2024-09-30   | $10.00B    | 21.07%        |
| 2024-06-30   | $10.22B    | 21.44%        |

**Analysis:** Revenue has been relatively stable over the past five quarters, with a slight dip in Q1 2025. Profit margins have been fluctuating.

| Quarter      | Equity     | ROE     |
|--------------|------------|---------|
| 2025-06-30   | $15.47B    | 7.59%   |
| 2025-03-31   | $14.98B    | 3.21%   |
| 2024-12-31   | $15.29B    | 8.27%   |
| 2024-09-30   | $14.75B    | 6.96%   |
| 2024-06-30   | $14.30B    | 6.57%   |

**Analysis:** Equity has shown a slight upward trend.  ROE (Return on Equity) has fluctuated, with a significant drop in Q1 2025.

### 7. Overall Summary

Overall, the analysis of NOC presents a mixed picture.

**Bearish Points:**

*   Significant underperformance compared to the S&P 500.
*   Negative expected return relative to the S&P 500.
*   Recent downward price trend (below moving averages).
*   Negative Alpha in recent periods, and fluctuating ROE
*   A hybrid signal gives a sell advice (Cash Ratio: 69%)

**Bullish Points:**

*   High Market Risk Indicator (MRI), suggesting broader market conditions are favorable for investment. (but Hybrid Signal is more cautious).
*   Oversold RSI could indicate a potential rebound.
*   Positive analyst consensus and target price suggest potential upside.
*   Recent news includes optimistic views on the company's growth.

**Conclusion:**

NOC's recent performance and technical indicators raise concerns. While analysts are generally positive and some news outlets see opportunities, the company's underperformance relative to the S&P 500, negative expected return, and recent price declines warrant caution. A potential investor should consider these factors and do further due diligence, especially focusing on the reasons behind the negative Alpha and the company's plans to improve its ROE and overall performance.
